News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

Artificial Intelligence/Machine Learning

Latest News

Image credit: Kaikoro | stock.adobe.com

February 27th 2024

Artificial Intelligence Drives Industry Response to Project Optimus

By Sirj Goswami, PhD, and Jason Rizzo, MBA

The FDA has taken a clear position with Project Optimus in shifting toward more progressive tailored approaches while rejecting antiquated study designs to evolve clinical trial strategies to better align with newer drug classes.

November 15th 2023

Artificial Intelligence Has the Potential to Transform Clinical Trials, Study Says

By Don Tracy, Associate Editor

Latest Videos

2025 DIA Global Annual Meeting: Public Sector Sets the Pace for AI in Drug Discovery and Approval

2025 DIA Global Annual Meeting: Public Sector Sets the Pace for AI in Drug Discovery and Approval

Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma

Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma

The Future of Drug Discovery: AI-Powered Predictions and Virtual Patient Models

The Future of Drug Discovery: AI-Powered Predictions and Virtual Patient Models

How AI Lowers the Real-World Barriers to Trial Participation

How AI Lowers the Real-World Barriers to Trial Participation

The Role of AI in Solving Clinical Trial Diversity and Access Challenges

The Role of AI in Solving Clinical Trial Diversity and Access Challenges

A Roadmap for the Use of Artificial Intelligence in Managing Trial Master Files

A Roadmap for the Use of Artificial Intelligence in Managing Trial Master Files

Leading the Technology and Innovation Front Through Rare Disease Research

Leading the Technology and Innovation Front Through Rare Disease Research

Addressing Clinical Trial Challenges Through AI and Scalable Solutions

Addressing Clinical Trial Challenges Through AI and Scalable Solutions

Executing with Clinical Technology

Executing with Clinical Technology

Addressing Data and Patient Retention Challenges

Addressing Data and Patient Retention Challenges

More News

Trending on Applied Clinical Trials Online

FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development

Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches

Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations

ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI

New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN